Last reviewed · How we verify
NCT03955874: IOS
Mechanical Ventilation Discontinuation Practices
trial in Invasive Mechanical Ventilation in 1,868 participants. Completed in 17 December 2016.
17 December 2016
Quick facts
| Lead sponsor | Unity Health Toronto |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,868 |
| Start date | 4 November 2013 |
| Primary completion | 17 December 2016 |
| Estimated completion | 17 December 2016 |
| Sites | 14 locations across Canada, United States |
Conditions studied
- Invasive Mechanical Ventilation — all drugs for Invasive Mechanical Ventilation →
- Critical Illness — all drugs for Critical Illness →
- Spontaneous Breathing Trial — all drugs for Spontaneous Breathing Trial →
- Weaning Invasive Mechanical Ventilation — all drugs for Weaning Invasive Mechanical Ventilation →
Sponsor
Unity Health Toronto — full company profile →
Who can join
16 and older, any sex, with Invasive Mechanical Ventilation or Critical Illness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: The requirement for ventilator support is a defining feature of critical illness. Weaning is the process during which the work of breathing is transferred from the ventilator back to the patient. Approximately 40% of the total time spent on ventilators is dedicated to weaning. The extent of practice variation in how this complex and expensive technology is discontinued from critically ill patients is unknown. Meanwhile, practice variation has been shown to adversely impact upon patient safety and clinical outcomes. Purpose: To characterize practice pattern variation in weaning and the consequences of weaning variation by implementing an international, prospective observational study in Canada, the United States, the United Kingdom, Europe, India and Australia/New Zealand. Primary Objectives: To describe 1. weaning practice variation among regions in 5 domains (the use of daily screening, preferred methods of support used before initial discontinuation attempts, use of written protocols, preferred methods of evaluating spontaneous breathing, and sedation and mobilization practices). 2. the assocation between selected discontinuation strategies and important clinical outcomes (length of stay, mortality, duration of ventilation). Methods: The investigators propose to conduct a large scale, observational study involving critically ill adults requiring ventilator support for at least 24 hours to evaluate practices in discontinuing ventilators in 150 centres. The investigators will classify each new admission over the observation period according to the initial strategy that precipitated or facilitated ventilator discontinuation. Relevance: This novel study will build collaborations with critical care investigators from around the world and industry
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Ventilator Weaning and Discontinuation Practices for Critically Ill Patients.
Burns KEA, Rizvi L, Cook DJ, Lebovic G, et al · · 2021 · cited 95× · PMID 33755077 · DOI 10.1001/jama.2021.2384 -
Variation in the practice of discontinuing mechanical ventilation in critically ill adults: study protocol for an international prospective observational study.
Burns KEA, Rizvi L, Cook DJ, Dodek P, et al · · 2019 · cited 4× · PMID 31501132 · DOI 10.1136/bmjopen-2019-031775
Verify or expand the search:
- PubMed search for NCT03955874
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Invasive Mechanical Ventilation
Currently open trials in the same condition.
- NCT06805357 — Lung Recruitment During Chest Physiotherapy in Mechanically Ventilated Patients · NA · recruiting
- NCT06531005 — Assessment of Ventilation Parameters for Extubation Prediction in ICU · recruiting
- NCT06404294 — The External Diaphragm Pacemaker Assisted Extubation in Premature Infants With Invasive Mechanical Ventilation · NA · recruiting
- NCT05668637 — Evaluation and Further Development of an Artificial Intelligence-based Algorithm for Clinical Decision Support · recruiting
Other Unity Health Toronto trials
Trials by the same sponsor.
- NCT07507409 — Innovative Sternal Closure Techniques: Evaluating STRATAFIX™ and DERMABOND™ for Reduced Complications in CABG Patients · Phase 4 · not yet recruiting
- NCT07455487 — First Appendectomy Using Revolve Surgical Robotic Arm · NA · not yet recruiting
- NCT07301632 — Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial · Phase 2 · recruiting
- NCT07314905 — Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp) · Phase 3 · not yet recruiting
- NCT06571916 — Brief Skills for Safer Living (Brief-SfSL) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03955874 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Unity Health Toronto
- Last refreshed: 2 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03955874.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing